AI-generated summary
The authors retrospectively reviewed 28 patients with rosacea treated with dye laser at one hospital, quantifying redness and blueness from clinical photographs. Dye laser alone did not significantly improve papulopustular rosacea in five cases, while seven cases treated with dye laser plus long-pulse alexandrite laser showed significant improvement. The authors describe the combination as a promising option, but the small, uncontrolled cohort limits certainty.
- Participants
- 28
- Who or what was studied
- Patients with rosacea (13 erythematotelangiectatic, 12 papulopustular, 3 phymatous) treated with dye laser at Nagoya City University Hospital, April 2019 to March 2023
- Limits stated in the abstract
- Small, uncontrolled retrospective cohort with subgroups of only five and seven patients for papulopustular rosacea.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Rosacea is a chronic skin disease characterized by facial flushing, dilated blood vessels, rashes, and swelling and has a significant impact not only on the patient's appearance, but also on their quality of life. Dye laser has the effect of contracting dilated blood vessels by selectively being absorbed in oxidized hemoglobin, and as a result, it improves flushing and dilated blood vessels. Dye laser is a useful option for erythematotelangiectatic rosacea (ETR). However, its effectiveness for papulopustular rosacea (PPR) is limited, and it is not recommended in several national guidelines. We examined the treatment effects of 28 cases diagnosed with rosacea and treated with dye laser therapy at Nagoya City University Hospital from April 2019 to March 2023. The cohort comprised 6 males, 22 females, 13 cases of ETR, 12 cases of PPR, and 3 cases of phymatous rosacea (PhyR). The evaluation was based on clinical photographs, and the redness and blueness of the skin were deconvoluted and quantified using ImageJ/Fiji software. In the case of ETR, there was a significant improvement between before and after treatment (p = 0.039). In the case of PPR, there was no significant improvement in the five cases treated with dye laser alone (p = 0.083). Still, there was significant improvement in the seven cases treated with a combination of long-pulse alexandrite (LPA) laser (p = 0.0024). A multiple logistic regression analysis was performed on the combined therapies other than LPA laser, including topical corticosteroids, tacrolimus, metronidazole, sulfur and camphor, azelaic acid, antibiotics, or vitamin B. No treatment was found to contribute to significant improvement. LPA laser is expected to reduce inflammation around hair follicles seen in PPR effectively, and its combination with dye laser is a promising treatment option for PPR. Furthermore, this quantitative method based on clinical photographs is useful for the objective evaluation of rosacea treatment.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.